Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 16 2014
Print

Accelrys Acquires QUMAS



By Kristin Brooks



Published December 10, 2013
Related Searches: Manufacturing
Accelrys, Inc. has acquired QUMAS, a global provider of cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations, for approximately $50 million in cash. The acquisition expands Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions.
 
QUMAS, based in Ireland, provides an electronic document management application with related R&D submission and QA documentation packages based on customer and industry requirements and best practices. The business process management applications include CAPA (corrective action/preventive action), audit, change control, deviation, complaint and other critical process packages offering pre-defined and pre-tested software configurations addressing common compliance challenges.
 
“As Accelrys continues to extend its research, laboratory and manufacturing informatics capabilities to deliver first-in-class scientific innovation lifecycle management (SILM) solutions, we’re delighted to welcome the QUMAS team and the extensive compliance, quality and regulatory expertise they bring to our company,” said Accelrys president and chief executive officer Max Carnecchia. “Integrating QUMAS solutions into the Accelrys product portfolio will provide a single-vendor SILM solution that is already in high demand for product lifecycle management into the critical compliance and quality management arena for science-based process industries.”
 
“In connecting science to business and in bridging the scientific and business communities through our compliance and quality solutions, QUMAS is delighted to join forces with Accelrys to help deliver this comprehensive, single-source compliance solution for the lab-to-plant continuum,” said QUMAS chief executive officer Kevin O’Leary. “Joining the market leader in scientific innovation lifecycle management enables QUMAS to extend its strong customer momentum into other business areas currently served by Accelrys.”


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On